Serum Uric Acid Levels and Onset of Cardiovascular Diseases: a CALIBER Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

180000 participants

Study Classification

OBSERVATIONAL

Study Start Date

1998-01-31

Study Completion Date

2019-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Serum uric acid level is a commonly measured biomarker. The association between serum uric acid level and the risk of developing cardiovascular diseases has been observed in some studies, while others showed controversial results. Estimation of this association may help to predict cardiovascular outcomes and may guide new treatment strategies. The hypothesis is that increased serum uric acid level is associated with a range of cardiovascular diseases.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Heart Rate and Cardiovascular Diseases Prognosis in People With Stable Coronary Artery Disease

NCT02244853

Stable Angina Myocardial Infarction Coronary Heart Disease +6 more

UNKNOWN

White Blood Cell Counts and Onset of Cardiovascular Diseases: a CALIBER Study

NCT02014610

Abdominal Aortic Aneurysm Coronary Artery Disease Stroke +2 more

UNKNOWN

Uric Acid Levels and Endothelial Functions

NCT02862522

Coronary Artery Disease

COMPLETED

Social Deprivation and Initial Presentation of 12 Cardiovascular Diseases: a CALIBER Study

NCT01937065

Abdominal Aortic Aneurysm Coronary Heart Disease NOS Unheralded Corronary Death +11 more

UNKNOWN

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

NCT02176174

Abdominal Aortic Aneurysm Coronary Heart Disease Sudden Cardiac Death +11 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Smaller observational studies suggested that increased serum uric acid level is associated with increased incidence of several cardiovascular diseases. Associations with specific initial presentations of cardiovascular diseases have not been studied in large cohort from the general population, but may be of interest for use in risk prediction or to guide therapeutic strategies.

The aim of this study is to estimate associations between serum uric acid level and initial presentation of a range of cardiovascular diseases.

The study will use data from the CALIBER dataset of clinically collected electronic health record data from England. Patients enter the study when they have a blood urate measurement recorded in the dataset, and they are followed up until they experience one of the cardiovascular endpoints, death or transfer out of the participating primary care practice.

This study is part of the CALIBER (Clinical disease research using linked bespoke studies and electronic records) programme funded from the National Institute for Health Research (NIHR) and Wellcome Trust. The central theme of the CALIBER research is linkage of the Inpatient Hospital Episode Statistics (HES) with primary care (Clinical Practice Research Datalink) and other resources. The overarching aim of CALIBER is to better understand the aetiology and prognosis of specific coronary phenotypes across a range of causal domains, particularly where electronic records provide a contribution beyond traditional studies. CALIBER has received both Ethics approval (ref 09/H0810/16) and ECC approval (ref ECC 2-06(b)/2009 CALIBER dataset).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stable Angina Unstable Angina Myocardial Infarction Unheralded Coronary Heart Disease Death Heart Failure Cardiac Arrest Transient Ischaemic Attack Ischemic Stroke Subarachnoid Hemorrhage Intracerebral Hemorrhage Peripheral Arterial Disease Abdominal Aortic Aneurysm Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients registered with a participating general practice during the study period
* Age 30 years or older at study entry
* No record of previous diagnosis of cardiovascular disease
* Follow up for at least one year before the index date.